scispace - formally typeset
A

Alison M. Dunning

Researcher at University of Cambridge

Publications -  473
Citations -  45416

Alison M. Dunning is an academic researcher from University of Cambridge. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 99, co-authored 437 publications receiving 39481 citations. Previous affiliations of Alison M. Dunning include Cambridge University Hospitals NHS Foundation Trust & Sheba Medical Center.

Papers
More filters
Journal ArticleDOI

Genome-wide association study identifies novel breast cancer susceptibility loci

Douglas F. Easton, +109 more
- 28 Jun 2007 - 
TL;DR: To identify further susceptibility alleles, a two-stage genome-wide association study in 4,398 breast cancer cases and 4,316 controls was conducted, followed by a third stage in which 30 single nucleotide polymorphisms were tested for confirmation.
Journal ArticleDOI

Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies

TL;DR: Paul Pharoah and colleagues evaluate the prognostic significance of immunohistochemical subtype classification in more than 10,000 breast cancer cases with early disease, and examines the influence of a patient's survival time on the prediction of future survival.
Journal ArticleDOI

Large-scale genotyping identifies 41 new loci associated with breast cancer risk

Kyriaki Michailidou, +220 more
- 01 Apr 2013 - 
TL;DR: A meta-analysis of 9 genome-wide association studies, including 10,052 breast cancer cases and 12,575 controls of European ancestry, and identified 29,807 SNPs for further genotyping suggests that more than 1,000 additional loci are involved in breast cancer susceptibility.
Journal ArticleDOI

Association analysis identifies 65 new breast cancer risk loci

Kyriaki Michailidou, +396 more
- 02 Nov 2017 - 
TL;DR: A genome-wide association study of breast cancer in 122,977 cases and 105,974 controls of European ancestry and 14,068 cases and 13,104 controls of East Asian ancestry finds that heritability of Breast cancer due to all single-nucleotide polymorphisms in regulatory features was 2–5-fold enriched relative to the genome- wide average.
Journal ArticleDOI

RAD51B in Familial Breast Cancer

Liisa M. Pelttari, +115 more
- 05 May 2016 - 
TL;DR: It is suggested that loss-of-function mutations in RAD 51B are rare, but common variation at the RAD51B region is significantly associated with familial breast cancer risk.